| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 1e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |